Nov 12, 2024 · Skyrizi (risankizumab-rzaa) is a brand-name drug that’s prescribed for adults with Crohn’s disease. This article covers topics such as side effects, dosage, and how Skyrizi works.

Learn about SKYRIZI® dosing for treating adults with moderate to severe Crohn’s disease and how to take SKYRIZI®. See full Safety & Prescribing Info.

Drug-induced liver injury was reported in a patient with Crohn’s disease who was hospitalized for a rash during induction dosing of SKYRIZI. For the treatment of Crohn's disease and …

Patients should be evaluated for tuberculosis (TB) prior to starting this medication, and should not be given Skyrizi® if there is active TB. If there is a hypersensitivity reaction or anaphylaxis …

How Does Skyrizi Work for Crohn’s Disease? Crohn’s disease is a type of inflammatory bowel disease (IBD), which causes irritation and swelling (inflammation) in the intestines.

Nov 11, 2025 · Skyrizi (risankizumab) is an injection used to treat plaque psoriasis, psoriatic arthritis, ulcerative colitis, and Crohn's disease. Includes indications, doses, interactions, side …

DOSAGE AND ADMINISTRATION For the treatment of Crohn’s disease and ulcerative colitis: Obtain liver enzymes and bilirubin levels prior to initiating treatment with SKYRIZI. (2.1, 5.4) …

4 days ago · Updated approval length for Skyrizi IV to 8 weeks. Effective 12/1/24. 10/09/2024 – Reviewed and updated for October P&T. Updated Crohn’s disease criteria to require …

Risankizumab, sold under the brand name Skyrizi (/ skaɪˈrɪzi / sky-RIZZ-ee), is a humanized monoclonal antibody used for the treatment of plaque psoriasis, psoriatic arthritis, Crohn's …

Aug 8, 2025 · Skyrizi (risankizumab-rzaa) is a brand-name drug used for plaque psoriasis, Crohn’s disease, and other conditions. Learn about side effects, uses, and more.